Hoʻopaʻa haʻawina hou i ke ʻano haʻahaʻa a i ke koʻikoʻi o ka osteoarthritis o ka kuli

A HOLD Hoʻokuʻu ʻole 3 | eTurboNews | eTN
i kakauia ma Linda Hohnholz

ʻO Ageless Biotech, Inc. Sheridan, WY he hui biotech i hoʻokumu ʻia e lawe mai i nā lāʻau lapaʻau e pili ana i ka cell cell i ka mākeke, ua loaʻa iā US Food and Drug Administration (FDA) Investigational New Drug Application (IND) no ka mālama ʻana i ka Osteoarthritis o ka Knee.              

Ua wehewehe ka Arthritis Foundation i ka Osteoarthritis ma ke ʻano he "maʻi maʻi ... me ka lāʻau ʻole." Ma kahi o hoʻokahi makahiki i hala aku nei i ka 2009 ABC News i paʻi ʻia, ʻo ka mālama olakino no nā maʻi osteoarthritis ma ʻAmelika Hui Pū ʻIa he $185.5 biliona i ka makahiki.

I loko o kahi pōkole 4 makahiki, mai ka 2009 Arthritis Foundation hōʻike i ke kumu kūʻai o OA ma USA i pālua ʻia e like me ka mea i paʻi ʻia ma 2013 e ka CDC hōʻike ʻo nā kumukūʻai Osteoarthritis makahiki "he $303.5 biliona a i ʻole 1% o ka 2013 US Gross Domestic Product (GDP) .”  

Ua kuhikuhi ka Pelekikena o Ageless Biotech, Inc, ʻo Vince Liguori, "ʻo ka loaʻa ʻana o kahi Stage II OA o ka Knee Clinical Trial hiki iā mākou ke hoʻomaka i nā hoʻokolohua ʻoi aku ka wikiwiki me nā hoʻolālā e hoʻomaka i ka hopena o Malaki 2022. ʻO kēia FDA Accepted IND hiki iā Ageless ʻO Biotech e lawe mai i kahi huahana Osteoarthritis Stem Cell i nā kauka a me nā maʻi wikiwiki. "

Ke hoʻohana nei ka Ageless Biotech IND i nā pūnaʻi kumu Adipose Derived Stem Cells me ka ʻole o nā enzymes a i ʻole nā ​​​​kemika ʻē aʻe ma o ke kaʻina hana ponoʻī o kahi ʻano kaulana i kapa ʻia ʻo Stromal Vascular Fraction (SVF) e hana ana i kahi matrix o nā cell ola kanaka. Hoʻolālā ʻo Ageless Biotech e hōʻoia i nā waiwai regenerative o ka Ageless Biotech SVF Product ma mua o ka pau ʻana o kēia FDA Accepted Clinical Study i ka manawa like e hōʻike ana i ka palekana a me ka liʻiliʻi o ka manawa haʻahaʻa no ka mea maʻi. Manaʻo ʻo Ageless Biotech e hoʻololi ʻia nā miliona o nā ʻoki kuli i hoʻokahi makahiki. ʻOiai ke manaʻoʻiʻo nei mākou e laikini ʻia kēia ʻenehana i nā kauka no ka hāʻawi ʻana i ka lehulehu, ke ʻimi nei mākou i nā koho HLA Type Compliant "ma waho o ka papa" e hoʻomaikaʻi i kēlā mau lapaʻau i ka wā e hiki mai ana.

ʻO BioXstem National Sales Director, a me Ageless Biotech Board Member Jon Youngs i ʻoi aku ka maikaʻi ma ka ʻōlelo ʻana, "Ua hauʻoli nui mākou ma BioXstem i ka lilo ʻana i mea hoʻopukapuka ʻo Ageless Biotech i kēia manawa ʻaʻole mākou e kamaʻilio wale nei. Hiki iā mākou ke ʻōlelo maoli ke komo nei mākou i kahi FDA IND a me kahi ʻāpana o ke alakaʻi e holomua ana i ka lāʻau lapaʻau.

<

No ka mea kākau

Linda Hohnholz

Lunahooponopono no eTurboNews ma ka eTN HQ.

kakau
E hoʻomaopopo i
malihini
0 Comments
Nā ʻōlelo Hoʻohui Kūʻai
E nānā i nā ʻōlelo āpau
0
E aloha nui i kou mau manaʻo, e ʻoluʻolu.x
()
x
Kaʻana like i...